Traxion Sab De Cv Ord Shs GRPOF

RE:RE:RE:Question for respected legend Leafrider and others alike

[Tameraq2]

You are lying again. Who are you comparing TBP volume with ??? LPs trading on TSX?? TBP volume is very decent and better than many cannabis stocks trading on the TSX venture . Look at EMC, HVT, LDS, RTI, RVV .....Etc all have much lower volume than TBP. On the other hand TBP is trading heavily on other platforms than TSXV. Check out stockwatch the volume on TBP today is almost 600K. When You are trying hard to make TBP look bad that's when you start lying. Don't lie please.

gkmackdadzzz1 wrote: a new low for leafy!  unreal.  it's clear these is no "smart money" here as leafy like to believe.  

it even shows in the volume.....not sure how you think there was there was this huge insurgence of buyers.

LeafRider wrote:

Listen to this guy, he thinks Tetra should be posting videos of how successful and how great their clinical trails are going. I agree, but honestly they need to hold their cards close to them right now. First to market is important in any new pharmaceutical venture. The longer Tetra can get through all this and be first to market on a smokable cannabis product and be able to cross-investigate other ailments after the fact is huge for Tetra's program. People are going to be throwing money at Tetra at a shot at a decent warrant upwards in the +$2 range when they raise capital. Could you imagine if they end up raising a huge chunk of capital like $40-60 million?

That would look really good when you need to line up phase 3 clinicals on a massive product line. I'm thinking we're due to announce that we've added another product to our pipeline through our Research and Development partnership with Constance Therapeutics.

 NR link:
https://tetrabiopharma.com/investors/press-releases/press-release-details/2017/Tetra-Bio-Pharma-Reinforces-its-Development-Program-by-Signing-Research--Development-Agreement-with-Constance-Therapeutics-and-Receiving-Financial-Support-from-NSERC/default.aspx

...Constance Therapeutics has developed whole plant cannabis extracts that have shown significant clinical promise in the treatment of various forms of cancer and improved patient survival as well. In collaboration, Tetra and Constance Therapeutics now aim to define the therapeutic mechanism and demonstrate efficacy of these cannabis extracts in the treatment of human cancers. In accordance with Tetra's provisional patent announced on May 17th, 2017, the collaboration will focus on treating various forms of cancer driven by inappropriate Hedgehog signaling, including multiple forms of brain, blood, skin and bone cancers.

 

Constance Finley, Founder and CEO of Constance Therapeutics, Inc. said, "over the years, research has demonstrated that cannabinoids including specific terpenes, reduce and inhibit tumor growth in various animal models. Early clinical studies suggest cannabinoids enhance the effects of traditional cancer treatments with radiation therapy and help reduce the size of brain cancers, such as Glioma, compared to controls."

 

"We are very excited to achieve this co-development program with Constance Therapeutics" added Bernard Fortier, CEO of Tetra. "Their initial research is very promising and we are hopeful that together we can provide novel treatments for multiple forms of aggressive cancer to patients with limited therapeutic options. ".....


Facts, all facts!!  "Suck my nuts bashers!!"  -  x2

 

yunggeorgesoros wrote: When will Tetra be finished signing up all the patients/candidates for phase III?

If Tetra was smart they would post news releases about how well their phase III is doing when it starts obviously, and great stories of people with cancer using ppp001 in their tests, and really improving their quality of life although they know it's the end of the road. That will generate plenty of media and hopefully a much needed boost in share price. Even though we dont generate a whole lot of revenues we are still undervalued imo due to the fact that we are perfect buyout candidates... hopefully not anytime soon... more like 2019.

We WILL be seeing a jump in shareprice due to royal assent happening any week now, however, if all of you have seen the NR today, I'm sure you realized we will be having a sexy Q3.

Been holding long and strong since 13. and buying up until .63. Suck my nuts bashers i dont even see you